|

RYZ401 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • RayzeBio, Inc.1

Indications

  • Somatostatin Receptor1
  • Pancreatic NET1
  • Carcinoid1
  • Gastroenteropancreatic Neuroendocrine Tumor Disease1
  • GEP-NET1

Iowa City, Iowa1 trial

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Research Facility

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.